Literature DB >> 6629410

Glycophorin A inhibits lysis by the complement attack phase.

H Brauch, D Roelcke, U Rother.   

Abstract

A glycoprotein from human erythrocyte membranes has been found to inhibit lysis of target cells by the attack-phase components C5-C9 from human complement. The inhibiting molecule was purified and identified as glycophorin A. Thus, glycophorin A may have a regulatory function in the lytic complement attack on isologous cells.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6629410     DOI： 10.1016/S0171-2985(83)80053-9

Source DB:  PubMed          Journal:  Immunobiology        ISSN： 0171-2985            Impact factor:   3.144


  4 in total

Review 1.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

3.  Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.

Authors:  Denise V Tambourgi; Marcelo De Sousa Da Silva; Stephen J Billington; Rute M Gonçalves De Andrade; Fábio C Magnoli; J Glenn Songer; Carmen W Van Den Berg
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

4.  Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; T Wiedmer; P J Sims; W F Rosse
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.